MEP37808A - Dna encoding a novel rg1 polypeptide - Google Patents

Dna encoding a novel rg1 polypeptide

Info

Publication number
MEP37808A
MEP37808A MEP-378/08A MEP37808A MEP37808A ME P37808 A MEP37808 A ME P37808A ME P37808 A MEP37808 A ME P37808A ME P37808 A MEP37808 A ME P37808A
Authority
ME
Montenegro
Prior art keywords
polypeptide
novel
polypeptides
dna encoding
methods
Prior art date
Application number
MEP-378/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Richard Harkins
Deborah Parkes
Gordon Parry
Douglas W Schneider
Renate Steinbrecher
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of MEP37808A publication Critical patent/MEP37808A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
MEP-378/08A 1999-12-16 2000-12-15 Dna encoding a novel rg1 polypeptide MEP37808A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17237099P 1999-12-16 1999-12-16
US09/732,357 US6682902B2 (en) 1999-12-16 2000-12-07 DNA encoding a novel RG1 polypeptide
PCT/US2000/033901 WO2001044291A2 (en) 1999-12-16 2000-12-15 Polynucleotid encoding the rg1 polypeptide

Publications (1)

Publication Number Publication Date
MEP37808A true MEP37808A (en) 2011-05-10

Family

ID=26868022

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-378/08A MEP37808A (en) 1999-12-16 2000-12-15 Dna encoding a novel rg1 polypeptide

Country Status (32)

Country Link
US (5) US6682902B2 (xx)
EP (2) EP2048157B1 (xx)
JP (1) JP4979867B2 (xx)
KR (1) KR100752434B1 (xx)
CN (1) CN1297566C (xx)
AT (1) ATE440862T1 (xx)
AU (1) AU784674B2 (xx)
BG (1) BG65898B1 (xx)
BR (1) BR0017022A (xx)
CA (1) CA2394574A1 (xx)
CZ (1) CZ299232B6 (xx)
DE (1) DE60042836D1 (xx)
DK (1) DK1237915T3 (xx)
EE (1) EE05293B1 (xx)
ES (1) ES2331106T3 (xx)
HR (1) HRP20020549B1 (xx)
HU (1) HU229001B1 (xx)
IL (2) IL150115A0 (xx)
LT (1) LT5046B (xx)
ME (1) MEP37808A (xx)
MX (1) MXPA02005914A (xx)
NO (1) NO330924B1 (xx)
NZ (1) NZ519598A (xx)
PL (1) PL207634B1 (xx)
PT (1) PT1237915E (xx)
RO (1) RO122543B1 (xx)
RS (1) RS50831B (xx)
RU (1) RU2283130C2 (xx)
SI (2) SI1237915T1 (xx)
SK (2) SK288147B6 (xx)
WO (1) WO2001044291A2 (xx)
ZA (1) ZA200205638B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020161199A1 (en) * 1998-04-08 2002-10-31 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
NZ528700A (en) * 1998-04-08 2005-02-25 Genentech Inc Novel PRO866 polypeptides and nucleic acids with homology to mindin and spondin proteins
US6960433B1 (en) 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US20070031901A1 (en) * 1999-03-08 2007-02-08 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US6682902B2 (en) * 1999-12-16 2004-01-27 Schering Aktiengesellschaft DNA encoding a novel RG1 polypeptide
EP1648510B1 (en) 2003-07-22 2013-06-19 Bayer Pharma Aktiengesellschaft Rg1 antibodies and uses thereof
US7294704B2 (en) 2003-08-15 2007-11-13 Diadexus, Inc. Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
US7785591B2 (en) 2004-10-14 2010-08-31 Morphosys Ag Identification and characterization of function-blocking anti-ED-B-fibronectin antibodies
TWI438207B (zh) * 2007-02-21 2014-05-21 Oncotherapy Science Inc 表現腫瘤相關抗原之癌症的胜肽疫苗
EP2211908A2 (en) * 2007-11-30 2010-08-04 Bristol-Myers Squibb Company Conjugates of anti-rg-1 antibodies
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
CN102346184B (zh) * 2010-08-03 2014-03-26 中国人民解放军军事医学科学院生物工程研究所 Spon2的新用途
DE202012012998U1 (de) 2011-08-31 2014-06-13 Daniel Elias Bioaktive, regenerative Mischung zur Herstellung eines Ergänzungsnahrungsmittels

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657760A (en) 1979-03-20 1987-04-14 Ortho Pharmaceutical Corporation Methods and compositions using monoclonal antibody to human T cells
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5206344A (en) 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5246692A (en) * 1986-09-05 1993-09-21 The United States Of America As Represented By The Secretary Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US4831175A (en) * 1986-09-05 1989-05-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US5437994A (en) 1989-06-15 1995-08-01 Regents Of The University Of Michigan Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5399493A (en) 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
US5225212A (en) 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
US6150584A (en) * 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
DE69127627T2 (de) 1990-08-29 1998-02-19 Genpharm Int Produktion und Nützung nicht-menschliche transgentiere zur Produktion heterologe Antikörper
US5877397A (en) 1990-08-29 1999-03-02 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
EP0641212A4 (en) 1992-05-14 1997-05-21 Ribozyme Pharm Inc PROCESS AND REAGENT FOR PREVENTING THE DEVELOPMENT OF CANCER.
US5871969A (en) 1996-02-12 1999-02-16 Human Genome Sciences, Inc. Nucleic acids encoding human neuronal attachment factor-1
US6177244B1 (en) 1996-05-10 2001-01-23 Beth Israel Deaconess Medical Center Inc. NPG-1 gene that is differentially expressed in prostate tumors
US6287777B1 (en) 1996-05-10 2001-09-11 Beth Israel Deaconess Medical Center NPG-1 gene that is differentially expressed in prostate tumors
US5804382A (en) 1996-05-10 1998-09-08 Beth Israel Deaconess Medical Center, Inc. Methods for identifying differentially expressed genes and differences between genomic nucleic acid sequences
JP3494529B2 (ja) * 1996-06-06 2004-02-09 Ｙｋｋ株式会社 一体成形面ファスナー
EP0933994A4 (en) * 1996-08-26 2002-09-18 Univ Washington THERAPEUTIC AND DIAGNOSTIC APPLICATIONS OF SPLICE VARIANTS OF THE PERLECAN I AREA
AU6961398A (en) 1997-04-10 1998-10-30 Zymogenetics Inc. Secreted f-spondin homologs
CA2289116A1 (en) * 1997-05-06 1998-11-12 Human Genome Sciences, Inc. Enterococcus faecalis polynucleotides and polypeptides
WO1998050073A1 (en) 1997-05-09 1998-11-12 Smithkline Beecham Corporation Integrin ligand, human mindin
EP1490386B1 (en) 1998-03-10 2008-08-13 Genentech, Inc. Novel polypeptide and nucleic acids encoding the same
US6166176A (en) * 1998-03-17 2000-12-26 Immvarx, Inc. Cancer marker protein and peptides thereof
US6960433B1 (en) * 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
WO2000023108A1 (en) 1998-10-19 2000-04-27 Diadexus Llc Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
EE05627B1 (et) * 1998-12-23 2013-02-15 Pfizer Inc. CTLA-4 vastased inimese monoklonaalsed antikehad
US6824780B1 (en) * 1999-10-29 2004-11-30 Genentech, Inc. Anti-tumor antibody compositions and methods of use
US6682902B2 (en) 1999-12-16 2004-01-27 Schering Aktiengesellschaft DNA encoding a novel RG1 polypeptide

Also Published As

Publication number Publication date
EE05293B1 (et) 2010-04-15
EE200200323A (et) 2003-10-15
HRP20020549A2 (en) 2004-04-30
SI21140A (sl) 2003-08-31
ES2331106T3 (es) 2009-12-22
DK1237915T3 (da) 2009-11-16
SI1237915T1 (sl) 2009-12-31
AU784674B2 (en) 2006-05-25
KR20020065575A (ko) 2002-08-13
US7307154B2 (en) 2007-12-11
JP4979867B2 (ja) 2012-07-18
CN1434832A (zh) 2003-08-06
NO20022836D0 (no) 2002-06-14
HUP0204224A2 (hu) 2003-03-28
EP1237915A2 (en) 2002-09-11
ATE440862T1 (de) 2009-09-15
EP2048157B1 (en) 2012-10-10
WO2001044291A2 (en) 2001-06-21
NO330924B1 (no) 2011-08-22
CA2394574A1 (en) 2001-06-21
MXPA02005914A (es) 2003-02-27
PT1237915E (pt) 2009-11-04
RS50831B (sr) 2010-08-31
HU229001B1 (en) 2013-07-29
CZ299232B6 (cs) 2008-05-21
BG65898B1 (bg) 2010-04-30
US20040152139A1 (en) 2004-08-05
BR0017022A (pt) 2002-11-05
RU2002119208A (ru) 2004-02-27
US20020004047A1 (en) 2002-01-10
KR100752434B1 (ko) 2007-08-27
RO122543B1 (ro) 2009-08-28
JP2003521244A (ja) 2003-07-15
AU3074601A (en) 2001-06-25
US7887804B2 (en) 2011-02-15
PL356220A1 (en) 2004-06-28
RU2283130C2 (ru) 2006-09-10
PL207634B1 (pl) 2011-01-31
NZ519598A (en) 2004-03-26
CN1297566C (zh) 2007-01-31
US7893217B2 (en) 2011-02-22
EP2048157A1 (en) 2009-04-15
SK288147B6 (sk) 2013-12-02
HRP20020549B1 (hr) 2013-09-30
LT2002070A (en) 2003-04-25
ZA200205638B (en) 2003-10-15
US20090214422A1 (en) 2009-08-27
IL150115A0 (en) 2002-12-01
DE60042836D1 (de) 2009-10-08
US20090292112A1 (en) 2009-11-26
LT5046B (lt) 2003-08-25
US6682902B2 (en) 2004-01-27
EP1237915B1 (en) 2009-08-26
YU44602A (sh) 2005-06-10
BG106823A (bg) 2003-04-30
HUP0204224A3 (en) 2004-12-28
SK286384B6 (sk) 2008-08-05
WO2001044291A3 (en) 2002-01-17
IL150115A (en) 2013-11-28
SK8482002A3 (en) 2003-02-04
US20040023307A1 (en) 2004-02-05
NO20022836L (no) 2002-08-15

Similar Documents

Publication Publication Date Title
MEP37808A (en) Dna encoding a novel rg1 polypeptide
DK0991763T3 (da) Modificeret adenovirusfiber og måladenovirus
DE69434926D1 (de) Menschlicher gewebsinhibitor von metalloproteinase-4
DK0750672T3 (da) DNA-sekvenser for matrix-metalproteaser, deres tilvejebringelse og anvendelse
GR3026176T3 (en) Protein complexes having factor viii:c activity and production thereof
DE69935220D1 (de) Von menschlichem tumor stammendes polypeptidhormon phosphatonin
HRP20110430T1 (hr) Fsh glikozilacijski mutant
ATE246247T1 (de) Varianten des humanen rekombinanten interferon- gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität
ATE294236T1 (de) Promotor der tie rezeptor protein kinase
NO932057L (no) Ny dopamin-menneske-reseptor og dens anvendelser
NO20011460L (no) Cytokinreseptor zalphall
DE69233463D1 (de) Expression und reinigung von kloniertem humanen alpha-fetoprotein
DE60118359D1 (de) Humanische pellino-polypeptide
DE60039677D1 (de) Akt-3 nukleinsäure, polypeptide und deren verwendung
BR112022022615A2 (pt) Proteína nova e usos terapêuticos e cosméticos da mesma
ATE368740T1 (de) Die menschliche beta-1a-untereinheit des potential-abhängigen natriumkanals und deren verwendungen
HUP0001057A2 (hu) A szarvasmarhafélék laktációjával összefüggő fehérje (CD14), az azt kódoló gén és a fehérje B-sejt-aktiválásban való alkalmazása
HUP0300813A2 (hu) Gének, fehérjék és alkalmazásuk
MY143222A (en) Expression vector for animal cell
AR242636A1 (es) Gen con codificacion para actividad de factor estimulante de colonias de granulocitos humanos.
PT1309690E (pt) Mfq-111, uma nova proteina do tipo gtpase humana
SE0004828D0 (sv) Protein cluster II